Melissa B. Epperly - 19 Jan 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
Issuer symbol
ROIV
Transactions as of
19 Jan 2024
Net transactions value
$0
Form type
4
Filing time
23 Jan 2024, 21:00:30 UTC
Previous filing
18 Oct 2023
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +1,207 +5.9% $0.000000 21,538 19 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.